Not for everyone : Certain health conditions or life stages may make these drugs unsuitable
New GLP-1 receptor agonist formulations, such as once-weekly injectable and oral versions, are gaining traction, improving patient compliance and market reach
The New England Journal of Medicine, 372, 21972206
If we keep our focus on the conditions that matter most to womens lives, and build the tools to meet them responsibly, the postnatal cliff edge could become something else entirely: the moment the system finally catches her and delivers preventative healthcare
A Zn-MOF-GOx-based cascade nanoreactor promotes diabetic infected wound healing by NO release and microenvironment regulation
But one of the important things that you'll find interesting that I published on back in 2014 was that I'd gone through this big published database where someone had published all these genes they found VDREs in